#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hormone-dependent prostate cancer Breast cancer metastatic Ocular myasthenia Retinal dystrophy Cryoglobulinaemia Cataract Atypical haemolytic uraemic syndrome Oesophageal squamous cell carcinoma stage II Scedosporium infection Haemophagocytic lymphohistiocytosis Cardiac failure acute Germ cell cancer Dementia Cerebral amyloid angiopathy Waldenstrom's macroglobulinaemia recurrent More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome – Treatment Lymphangiosarcoma – Treatment Gastrointestinal stromal tumour – Trials in Disease Retinitis pigmentosa Phenylketonuria – Life with Disease Pemphigoid – Basic Information Erdheim-Chester disease – Life with Disease Brain stem glioma – Treatment Niemann-Pick disease – Basic Information Langerhans’ cell histiocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Belimumab HAFNIUM OXIDE Azelastine Hydrochloride Crisantaspase Chloropyramine Hydrochloride DESMOPRESSIN ACETATE Quinapril Hydrochloride MB-CART2219.1 Gsk3915393 Colecalciferol Acou085 Art0380 Mesilate Zinc Acetate Dihydrate Ucart20X22 Iph5201 Ptc518 Guanabenz Acetate Ivonescimab VISUGROMAB Hct116-B More therapies…

    Learn about Your Condition

    Lymphocytic leukaemia Choroidal neovascularisation Migraine without aura Erythema Immune system disorder Senile dementia Castleman's disease Varicella Endometrial stromal sarcoma Oxygen therapy Congenital myopathy Malignant mast cell neoplasm Systemic sclerosis pulmonary Pneumococcal infection Tonsillitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Budesonide Tablets for Treating Eosinophilic Esophagitis in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Budesonide
    Austria Germany Portugal Spain

  • Study on Bevacizumab-Based Chemotherapy for Patients with Unresectable Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Sodium Chloride
    France

  • Study on the Effectiveness and Safety of Vedolizumab, Budesonide, and Prednisone for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Budesonide
    • Prednisone
    Belgium Croatia Greece Hungary Italy Poland

  • Study on Levobupivacaine, Paracetamol, and Diclofenac for Pain Relief After Esophageal Lesion Procedure in Patients with Precancerous Esophageal Lesions

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Levobupivacaine Hydrochloride
    • Diclofenac Sodium
    • Paracetamol
    The Netherlands

  • Study on Crofelemer for Adults with Short Bowel Syndrome and Intestinal Failure Without Colon in Continuity

    Recruiting

    2 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Crofelemer
    Germany Italy

  • Study on the Effects of Atezolizumab, Bevacizumab, Oxaliplatin, and Capecitabine in Patients with Colorectal Cancer and Liver Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    • Metastases to liver
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Capecitabine
    France
Previous Page
1 … 21 22 23 24 25 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!